Swiss IKS Approves Formulation of Metronidazole in IV Bags

February 2000
Worldwide Biotech;Feb2000, Vol. 12 Issue 2, p4
Trade Publication
Focuses on the approval received by Bigmar Inc. from the Intercantonal Office for the Control of Medicine (IKS) in Switzerland to utilize IV bags as a drug delivery system for Metronidazole, an antibiotic for serious infections.


Related Articles

  • FDA Approves BigMar's Daunorubicin Hydrochloride For Injection.  // Worldwide Biotech;Jul99, Vol. 11 Issue 7, p7 

    Reports that Bigmar Inc. received the approval of the United States Food and Drug Administration (FDA) for its drug product, Daunorubicin Hydrochloride for Injection. Therapeutic use of Daunorubicin Hydrochloride for Injection; Other products of Bigmar approved by the FDA; Comments from John G....

  • Treatment for Trichomonas vaginalis.  // Modern Medicine;Aug94, Vol. 62 Issue 8, p26 

    Reports on the availability of the drug metronidazole in capsule form.

  • GMP Warning Letters. Bush, Laura // Pharmaceutical Technology;Oct2004, Vol. 28 Issue 10, p20 

    The article reports that the U.S. Food and Drug Administration issued two warning letters in August 2004 concerning violations of good manufacturing practices (GMP). On August 3, 2004 the Center for Drug Evaluation and Research sent a warning letter to Bioren SA, a subsidiary of generics...

  • Prevention of wound infection after appendectomy. Walling, Anne D. // American Family Physician;5/15/1998, Vol. 57 Issue 10, p2512 

    Presents information taken from the article `Preventing Infection of the Incision After Appendectomy by Using Metronidazole Preoperatively to Infiltrate Tissues at the Incision,' by W. Shubing and Z. Litian, which was published in the 1997 October issue of the `American Journal of Surgery.'...

  • metronidazole.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1459 

    A definition of the medical term "metronidazole," which refers to an antibiotic used to treat infections caused by Trichomonas vaginalis, Giardia lamblia, amebic dysentery, and anaerobic bacterial infections, is presented.

  • Metronidazole. Finegold, Sydney M. // Annals of Internal Medicine;Oct80, Vol. 93 Issue 4, p585 

    Focuses on the drug metronidazole. Characteristics of the drug; Pharmacology and mode of action when used; Therapeutic uses; Side effects.

  • Metronidazole.  // Reactions Weekly;9/25/2010, Issue 1320, p34 

    The article describes the case of a 32-year-old woman who developed psychosis following metronidazole treatment for rosacea.

  • Cefotaxime/metronidazole/oseltamivir.  // Reactions Weekly;10/6/2012, Issue 1422, p16 

    The article describes the case of a 22-year-old man with cholestatic hepatitis A virus who developed DRESS syndrome after receiving oseltamivir, metronidazole and cefotaxime.

  • Ciprofloxacin/glimepiride/metronidazole.  // Reactions Weekly;1/29/2011, Issue 1336, p13 

    The article describes the case of a 79-year-old man who presented with hypoglycaemia while receiving treatment with ciprofloxacin, glimepiride and metronidazole, referencing a study published in the December 2010 issue of the journal "Hospital Pharmacy."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics